Clopidogrel Bioactivation and Risk of Bleeding in Patients Cotreated With Angiotensin-Converting Enzyme Inhibitors After Myocardial Infarction: A Proof-of-Concept Study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clopidogrel Bioactivation and Risk of Bleeding in Patients Cotreated With Angiotensin-Converting Enzyme Inhibitors After Myocardial Infarction: A Proof-of-Concept Study
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 96, Issue 6, Pages 713-722
Publisher
Springer Nature
Online
2014-09-15
DOI
10.1038/clpt.2014.183
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function
- (2013) Andrew L. Frelinger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
- (2013) S. Casey Laizure et al. PHARMACOTHERAPY
- Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
- (2012) Morten Lamberts et al. CIRCULATION
- Comparative Pharmacokinetics and Pharmacodynamics of Platelet Adenosine Diphosphate Receptor Antagonists and their Clinical Implications
- (2012) Christopher N. Floyd et al. CLINICAL PHARMACOKINETICS
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
- (2012) Joshua P. Lewis et al. Pharmacogenetics and Genomics
- Clopidogrel–Drug Interactions
- (2011) Eric R. Bates et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Calcium-Channel Blockers Do Not Alter the Clinical Efficacy of Clopidogrel After Myocardial Infarction
- (2011) Jonas B. Olesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The pharmacogenetics of antiplatelet agents: towards personalized therapy?
- (2011) Tariq Ahmad et al. Nature Reviews Cardiology
- An automated database case definition for serious bleeding related to oral anticoagulant use
- (2011) Andrew Cunningham et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- High platelet reactivity and clinical outcome – Fact and fiction
- (2011) Dirk Sibbing et al. THROMBOSIS AND HAEMOSTASIS
- An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma
- (2011) Sebastien Roy et al. THROMBOSIS AND HAEMOSTASIS
- In Vitro Evaluation of Inhibitory Effects of Antidiabetic and Antihyperlipidemic Drugs on Human Carboxylesterase Activities
- (2010) T. Fukami et al. DRUG METABOLISM AND DISPOSITION
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: Potential sources of metabolic drug interactions
- (2010) Hao-Jie Zhu et al. TOXICOLOGY
- Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril
- (2009) Hao-Jie Zhu et al. BIOCHEMICAL PHARMACOLOGY
- In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations
- (2009) Giulio Vistoli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Different Inhibitory Effects in Rat and Human Carboxylesterases
- (2009) S. Takahashi et al. DRUG METABOLISM AND DISPOSITION
- A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and Clopidogrel
- (2009) K. Hagihara et al. DRUG METABOLISM AND DISPOSITION
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
- (2009) M. Kazui et al. DRUG METABOLISM AND DISPOSITION
- Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
- (2009) W. Kuliczkowski et al. EUROPEAN HEART JOURNAL
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis
- (2008) Hao-Jie Zhu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Initiation and persistence with clopidogrel treatment after acute myocardial infarction - a nationwide study
- (2008) Rikke Sørensen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quantitative determination of clopidogrel active metabolite in human plasma by LC–MS/MS
- (2008) Makoto Takahashi et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started